SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-16

Mon, Nov 16, 2026 - Page 44

8174 indexed SquawkNews stories from this UTC day. Showing 5161-5280.

EQUITY 4239EARNINGS 1763NEWS 316MACRO 256GEOPOLITICS 253MNA 237FX 219REGULATION 198CENTRAL_BANK 178COMMODITIES 169RATES 159ENERGY 131
L UBS Raises Lonza Group Price Target to CHF 765 From CHF 685 EQUITY | Nov 16, 2026, 12:18 PM UTC L US and Russia to Oppose Talks on Limiting Autonomous Weapons The United States and Russia will oppose talks on limiting autonomous weapons. GEOPOLITICS | Nov 16, 2026, 12:18 PM UTC M Blackstone Digital Infrastructure Trust to Buy 75% Stake in AWS Data Center Ventures Blackstone Digital Infrastructure Trust plans to acquire a 75% stake in AWS Data Center Ventures in a $5 billion deal. MNA | Nov 16, 2026, 12:18 PM UTC L POET Technologies reports record q3 2026 revenue of $1.03m, up 244% TORONTO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. EARNINGS | Nov 16, 2026, 12:18 PM UTC M FDA Approves AstraZeneca’s Klygefa for Generalized Myasthenia Gravis The FDA approved Klygefa (gefurulimab) for adults with generalized myasthenia gravis who are anti-acetyl… REGULATION | Nov 16, 2026, 12:18 PM UTC L Larimar Therapeutics Q3 2026 net loss narrows 35% to $31.14 million Larimar Therapeutics Q3 2026 net loss narrows 35% to $31.14 million Larimar Therapeutics’ third EQUITY | Nov 16, 2026, 12:18 PM UTC L Dem Senator Asks Lutnick To End Advanced Chips Flow To Firms W/ China Ties Dem Senator Asks Lutnick To End Advanced Chips Flow To Firms W/ China Ties GEOPOLITICS | Nov 16, 2026, 12:17 PM UTC L US Commerce Secretary Lutnick asked to end advanced chips flow to firms w/ China ties US Commerce Secretary Lutnick asked to end advanced chips flow to firms w/ China ties GEOPOLITICS | Nov 16, 2026, 12:17 PM UTC L NervGen Pharma 3Q Loss/Shr C$0.06 >NGEN NervGen Pharma 3Q Loss/Shr C$0.06 >NGEN EQUITY | Nov 16, 2026, 12:17 PM UTC L Clearwater Paper Appoints Matt Passarello CFO EQUITY | Nov 16, 2026, 12:17 PM UTC L NervGen (NGEN) Reports C$80.1M Cash, Runway Through RESTORE Data in 1H 2028 NervGen reported C$80.1M in cash and cash equivalents as of September 30, 2026, versus C$22.1M on December 31, 2025. The company expects these funds to last through anticipated RESTORE topline data in 1H 2028.Material De EQUITY | Nov 16, 2026, 12:16 PM UTC L Larimar Therapeutics (LRMR) Reports $31.1M Q3 Net Loss; Cash Runway Into Late Q2 2027 Larimar reported a Q3 2026 net loss of $31.1M, or $0.29 per share, versus $47.7M, or $0.61, in Q3 2025. It had $128.7M in cash, cash equivalents and marketable securities at September 30, 2026, and projects runway into l EQUITY | Nov 16, 2026, 12:16 PM UTC M Copper Intelligence Acquires Additional Congo Mining Assets, Completes Private Placement EQUITY | Nov 16, 2026, 12:16 PM UTC L MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Planning underway for ZEPHYR-2, the confirmatory Phase 3 trial of ML-007C-MA in schizophrenia, with topline results expected in 2028Enrollment ongoing in Phase 2 VISTA trial in Alzheimer’s disease psychosis, with topline REGULATION | Nov 16, 2026, 12:16 PM UTC L Cypherpunk Technologies posts Q3 profit on ZEC price gain OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Nov 16, 2026, 12:16 PM UTC L Cypherpunk Technologies posts Q3 profit on ZEC price gain Cypherpunk Technologies posts Q3 profit on ZEC price gain Overview US privacy technology firm's Q3 m EARNINGS | Nov 16, 2026, 12:16 PM UTC L NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) -- NervGen NASDAQ:NGEN, a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic a EQUITY | Nov 16, 2026, 12:16 PM UTC L MAPLIGHT THERAPEUTICS - Q3 NET LOSS $51.60 MLN, Q3 NET LOSS PER SHARE $0.97 MAPLIGHT THERAPEUTICS - Q3 NET LOSS $51.60 MLN, Q3 NET LOSS PER SHARE $0.97 EQUITY | Nov 16, 2026, 12:16 PM UTC L NERVGEN PHARMA CORP - Q3 NET LOSS WAS C$6.4 MLN, OR C$0.06 PER SHARE NERVGEN PHARMA CORP - Q3 NET LOSS WAS C$6.4 MLN, OR C$0.06 PER SHARE EQUITY | Nov 16, 2026, 12:16 PM UTC L BRIEF-Larimar Therapeutics Q3 Net Income USD -31.135 Million Nov 16 (Reuters) - Larimar Therapeutics Q3 income from operations USD -32.464 million. FX | Nov 16, 2026, 12:16 PM UTC L BRIEF-Larimar Therapeutics Q3 Net Income USD -31.135 Million BRIEF-Larimar Therapeutics Q3 Net Income USD -31.135 Million Nov 16 (Reuters) - Larimar Therapeutics FX | Nov 16, 2026, 12:16 PM UTC L AirJoule Technologies Names Timothy N. White to Board, Replacing Ajay Agrawal EQUITY | Nov 16, 2026, 12:16 PM UTC L CORRECTED-BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.13 CORRECTED-BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.13 Nov 16 (Reuters) - Cypherpunk Technologi EARNINGS | Nov 16, 2026, 12:15 PM UTC L Canadian cannabis producer Rubicon Organics Q3 revenue rises, but misses estimates OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re EARNINGS | Nov 16, 2026, 12:15 PM UTC L MapLight Therapeutics 3Q Loss/Shr 97c >MPLT MapLight Therapeutics 3Q Loss/Shr 97c >MPLT EQUITY | Nov 16, 2026, 12:15 PM UTC L Canadian cannabis producer Rubicon Organics Q3 revenue rises, but misses estimates Canadian cannabis producer Rubicon Organics Q3 revenue rises, but misses estimates Overview Canada p EARNINGS | Nov 16, 2026, 12:15 PM UTC M Granite Construction Completes Acquisition of Utah and Tennessee Businesses Granite Construction announced it completed the acquisition of businesses in Utah and Tennessee. MNA | Nov 16, 2026, 12:15 PM UTC L LARIMAR THERAPEUTICS Q3 EPS USD -0.29 LARIMAR THERAPEUTICS Q3 EPS USD -0.29 EARNINGS | Nov 16, 2026, 12:15 PM UTC L NERVGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES NERVGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES EQUITY | Nov 16, 2026, 12:15 PM UTC L LARIMAR THERAPEUTICS Q3 NET INCOME USD -31.135 MILLION LARIMAR THERAPEUTICS Q3 NET INCOME USD -31.135 MILLION FX | Nov 16, 2026, 12:15 PM UTC L LARIMAR THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -32.464 MILLION LARIMAR THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -32.464 MILLION FX | Nov 16, 2026, 12:15 PM UTC L MAPLIGHT THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE MAPLIGHT THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE EQUITY | Nov 16, 2026, 12:15 PM UTC L MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Plan EQUITY | Nov 16, 2026, 12:15 PM UTC L NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates Company plans to EQUITY | Nov 16, 2026, 12:15 PM UTC L Canaccord Genuity Upgrades York Space Systems to Buy, Sets $9 Target Canaccord Genuity raised its rating on York Space Systems to Buy from Hold and set a $9 price target. EQUITY | Nov 16, 2026, 12:15 PM UTC M Lilly to Acquire Calytrix Bio for Up to $1.5 Billion Lilly plans to acquire Calytrix Bio for up to $1.5 billion. EQUITY | Nov 16, 2026, 12:15 PM UTC L MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Planning underway for ZEPHYR-2, the confirmatory Phase 3 trial of ML-007C-MA in schizophrenia, with EQUITY | Nov 16, 2026, 12:15 PM UTC L Larimar Therapeutics 3Q Loss/Shr 29c >LRMR Larimar Therapeutics 3Q Loss/Shr 29c >LRMR EQUITY | Nov 16, 2026, 12:15 PM UTC L Larimar Therapeutics 3Q Loss $31.1M >LRMR Larimar Therapeutics 3Q Loss $31.1M >LRMR EQUITY | Nov 16, 2026, 12:15 PM UTC L NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates Company plans to request a multidisciplinary Type B meeting with FDA to discuss NVG-291’s continued REGULATION | Nov 16, 2026, 12:15 PM UTC L UniCredit Partners With Convention Bureau Italia on Southern Italy Conference Tourism UniCredit and Convention Bureau Italia are partnering to attract investment in conference tourism in southern Italy. EQUITY | Nov 16, 2026, 12:14 PM UTC L CORRECTED-CYPHERPUNK TECHNOLOGIES INC Q3 EPS USD 1.13 (CORRECTS AMOUNT) CORRECTED-CYPHERPUNK TECHNOLOGIES INC Q3 EPS USD 1.13 (CORRECTS AMOUNT) EARNINGS | Nov 16, 2026, 12:14 PM UTC M Lilly Agrees to Acquire Calytrix Bio Calytrix Bio entered an agreement to be acquired by Lilly. EQUITY | Nov 16, 2026, 12:14 PM UTC L Siemens Energy Supervisory Body Member Robert Kensbock Sells Shares Robert Kensbock sold Siemens Energy shares; the transaction value is not quantifiable from the available information. EQUITY | Nov 16, 2026, 12:14 PM UTC M Lilly to Buy Calytrix Bio for Up to $1.5 Billion MNA | Nov 16, 2026, 12:14 PM UTC L UNICYCIVE THERAPEUTICS Q3 EPS USD -0.25 UNICYCIVE THERAPEUTICS Q3 EPS USD -0.25 EARNINGS | Nov 16, 2026, 12:14 PM UTC L Deutsche Bank Raises Praxis Precision Medicines Target to $483 From $475 EQUITY | Nov 16, 2026, 12:14 PM UTC L Goldman Sachs ETF Trust Files Form N-CEN Goldman Sachs ETF Trust filed Form N-CEN for the period ending Aug. 31. EQUITY | Nov 16, 2026, 12:14 PM UTC L Cypherpunk Technologies Posts $306 Million Q3 Net Income on ZEC Fair-Value Gain Cypherpunk Technologies reported third-quarter 2026 net income of $306.0 million, compared with a $3.3 million loss a year earlier, as a non-cash gain on an embedded derivative contributed $330.8 million. Revenue was $9. EARNINGS | Nov 16, 2026, 12:13 PM UTC L Xtant Medical Q3 Revenue Falls to $24.3 Million; Net Loss of $3.6 Million Xtant Medical reported third-quarter 2026 revenue of $24.3 million and a net loss of $3.6 million, compared with revenue of $33.3 million and net income of $1.3 million a year earlier. Gross margin was 56.3%, and adjuste EARNINGS | Nov 16, 2026, 12:13 PM UTC L Invivyd Reports Q3 2026 Revenue of $15.4 Million and $33.5 Million Net Loss Invivyd reported third-quarter 2026 revenue of $15.4 million, up from $13.1 million a year earlier, and a net loss of $33.5 million. Cash and cash equivalents totaled $126.4 million at September 30, 2026. The company sai EARNINGS | Nov 16, 2026, 12:13 PM UTC L Siemens Energy Supervisory Body Member Robert Kensbock Sells Shares Siemens Energy supervisory body member Robert Kensbock sold shares; the transaction amount is not quantifiable. EQUITY | Nov 16, 2026, 12:13 PM UTC L Warren Buffett to Donate Portion of Berkshire Shares to Four Family Foundations EQUITY | Nov 16, 2026, 12:13 PM UTC L Gemspring Capital Forms Fourth Buyout Fund at $3.5 Billion EQUITY | Nov 16, 2026, 12:13 PM UTC L Aker BP Awards Executive Share Grants Under 2026–2029 Plan Aker BP awarded executive share grants under its 2026–2029 incentive plan. EQUITY | Nov 16, 2026, 12:13 PM UTC L TD Cowen Upgrades SPX Technologies to Buy From Hold, Sets $200 Target TD Cowen upgraded SPX Technologies to Buy from Hold and set a $200 price target. EQUITY | Nov 16, 2026, 12:13 PM UTC L Creative Media & Community Trust Q3 net loss widens on impairment charges OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EQUITY | Nov 16, 2026, 12:13 PM UTC L Creative Media & Community Trust Q3 net loss widens on impairment charges Creative Media & Community Trust Q3 net loss widens on impairment charges Overview U.S. real estate EQUITY | Nov 16, 2026, 12:13 PM UTC L Phillip Securities Upgrades Palantir to Buy From Neutral, Sets $248 Target EQUITY | Nov 16, 2026, 12:12 PM UTC L UBS Upgrades Peabody Energy to Buy From Hold, Sets $22 Target UBS upgraded Peabody Energy to Buy from Hold and set a $22 price target. The company has an average rating of overweight. EQUITY | Nov 16, 2026, 12:12 PM UTC H Tyson Q4 2026 Earnings Adj EPS: 61c (est 53c) - Sales: $14.59B (est $14.32B) - Loss/Share: 22c vs EPS 13c Y/Y - Sees 2027 Sales: -3.5% To -5.5% - Sees 2027 Net Interest Expenses: $360M (est $355.7M) - Sees 2027 Capex: $1.1B To $1.4B (est $965. EARNINGS | Nov 16, 2026, 12:12 PM UTC M China Development Bank Financial Leasing Signs RMB 9.68 Billion Equipment Deal China Development Bank Financial Leasing signed a RMB 9.68 billion deal to purchase computer equipment. EQUITY | Nov 16, 2026, 12:12 PM UTC L Providus CLO IV Gives Notice of Amended Transaction Document Providus CLO IV Designated Activity Company issued a notice to noteholders regarding an amended transaction document. RATES | Nov 16, 2026, 12:12 PM UTC L Invivyd Q3 revenue rises on PEMGARDA demand, loss per share less than expected OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Nov 16, 2026, 12:12 PM UTC L Prelude Therapeutics Q3 2026 net loss narrows 36% to $12.54 million Prelude Therapeutics Q3 2026 net loss narrows 36% to $12.54 million Prelude Therapeutics’ third EQUITY | Nov 16, 2026, 12:12 PM UTC L Canada's POET Technologies Q3 revenue jumps, net loss narrows OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Nov 16, 2026, 12:12 PM UTC L Invivyd Q3 revenue rises on PEMGARDA demand, loss per share less than expected Invivyd Q3 revenue rises on PEMGARDA demand, loss per share less than expected Overview US biopharma EARNINGS | Nov 16, 2026, 12:12 PM UTC M POET Technologies Q3 Revenue Rises as Net Loss Narrows POET Technologies reported higher third-quarter revenue and a narrower net loss. EQUITY | Nov 16, 2026, 12:11 PM UTC M HDFC Life Insurance to Raise Up to ₹500 Crore Through NCD Issue HDFC Life approved issuing subordinated non-convertible debentures on a private-placement basis. EQUITY | Nov 16, 2026, 12:11 PM UTC L GT Biopharma posts Q3 net loss; R&D expenses rise OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re EQUITY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Lowers 1Q27 WTI Forecast to $85/bbl Goldman Sachs lowered its 1Q27 WTI forecast to $85 per barrel from $87 previously. ENERGY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Cuts 2026 WTI Forecast to $85/bbl The bank lowered its 2026 WTI forecast from $87/bbl previously. ENERGY | Nov 16, 2026, 12:11 PM UTC L Chip Tensions Loom Over Trump-Xi Summit as US and China Push AI Safety Steps A report frames chip tensions as an issue for the Trump-Xi summit and says the US and China are pushing AI safety steps. GEOPOLITICS | Nov 16, 2026, 12:11 PM UTC L GT Biopharma posts Q3 net loss; R&D expenses rise GT Biopharma posts Q3 net loss; R&D expenses rise Overview Immuno-oncology firm posts Q3 net loss of EQUITY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Lowers 4Q26 WTI Forecast to $91/bbl Goldman Sachs lowered its 4Q26 WTI forecast to $91/bbl from $96/bbl previously. ENERGY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Lowers 1Q27 Brent Forecast to $96/bbl Goldman Sachs cut its 1Q27 Brent crude forecast from $98/bbl to $96/bbl. ENERGY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Lowers 2026 Brent Forecast to $92/bbl Goldman Sachs cut its 2026 Brent crude forecast from $93/bbl to $92/bbl. ENERGY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Lowers 4Q26 Brent Forecast to $103/bbl Goldman Sachs lowered its 4Q26 Brent crude forecast to $103/bbl from $108/bbl previously. ENERGY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs Announces $72 Price Target for Somnigroup International EQUITY | Nov 16, 2026, 12:11 PM UTC L Goldman Sachs ETF Trust Files Form N-CEN The filing covers the period ended Aug. 31 and was filed Nov. 16. EQUITY | Nov 16, 2026, 12:11 PM UTC L Prelude Therapeutics Q3 net loss narrows as expenses fall OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EQUITY | Nov 16, 2026, 12:10 PM UTC M Steppe Gold Q3 Net Profit and Comprehensive Income Rises 07:10 AM EST, 11/16/2026 (MT Newswires) -- Steppe Gold (STGO.TO) reported third quarter net EPS of $ EARNINGS | Nov 16, 2026, 12:10 PM UTC M L3Harris Shares Fall 4.2% Premarket After Officials Blame Router Installation for Aviation Shutdown Officials blamed L3Harris’s router installation for a US aviation shutdown, and the company’s shares fell 4.2% premarket. EQUITY | Nov 16, 2026, 12:10 PM UTC L Prelude Therapeutics Q3 net loss narrows as expenses fall Prelude Therapeutics Q3 net loss narrows as expenses fall Overview US precision oncology firm's Q3 r EQUITY | Nov 16, 2026, 12:10 PM UTC L Evogene Chairman Nir Nimrodi Resigns From Board Evogene chairman Nir Nimrodi notified the board of his resignation. EQUITY | Nov 16, 2026, 12:10 PM UTC L US Research Roundup: NVIDIA, Phillips 66, TransDigm Group EQUITY | Nov 16, 2026, 12:10 PM UTC L Minerva Neurosciences Expects Roluperidone C19 Trial Results in Second Half of Next Year Minerva Neurosciences Expects Roluperidone C19 Trial Results in Second Half of Next Year Minerva EQUITY | Nov 16, 2026, 12:10 PM UTC M Medtronic to Acquire Contego Medical Medtronic says it will acquire Contego Medical, expanding access to next-generation carotid therapies. EQUITY | Nov 16, 2026, 12:10 PM UTC L Trump’s Nvidia Holdings Reportedly Reached Up to $62 Million Washington Post analysis of Trump’s financial disclosures indicates he held between $13 million and $62 million in Nvidia stock at the end of August. The filings do not capture trades from the past two… EQUITY | Nov 16, 2026, 12:10 PM UTC L Trump’s Nvidia stake grew to as much as $62 million, report says The Washington Post reported that Trump’s Nvidia stake grew to as much as $62 million. EQUITY | Nov 16, 2026, 12:10 PM UTC L Invivyd Names Chairman Marc Elia CEO Invivyd appointed board Chairman Marc W. Elia chief executive. EQUITY | Nov 16, 2026, 12:09 PM UTC M AirJoule Completes BitSink Acquisition, Sets 2027 Revenue Outlook AirJoule Technologies completed its acquisition of BitSink and set a 2027 revenue outlook. MNA | Nov 16, 2026, 12:09 PM UTC L US Research Roundup: NVIDIA, Phillips 66, TransDigm Group A Reuters item lists research coverage of NVIDIA, Phillips 66 and TransDigm Group; no specific analyst actions are provided. EQUITY | Nov 16, 2026, 12:09 PM UTC L Eloxx Pharmaceuticals Q3 net loss widens on higher costs Eloxx Pharmaceuticals Q3 net loss widens on higher costs Overview US rare kidney disease drug develo EQUITY | Nov 16, 2026, 12:09 PM UTC L Instil Bio Q3 net loss narrows on lower expenses Instil Bio Q3 net loss narrows on lower expenses Overview Biotechnology company's Q3 net loss narrow EQUITY | Nov 16, 2026, 12:09 PM UTC M Xtant Medical Withdraws 2026 Guidance After $3.6M Q3 Loss Q3 revenue was $24.3 million, down from $33.3 million a year earlier but up 5% sequentially. Xtant reported a $3.6 million net loss, versus $1.3 million in net income a year earlier, and withdrew its prior 2026 guidance EQUITY | Nov 16, 2026, 12:09 PM UTC L Corporación América Airports subsidiary Aeropuertos Argentina 2000 posts Q3 net income of 69.57 billion Argentine pesos, up from 37.22 billi Corporación América Airports subsidiary Aeropuertos Argentina 2000 posts Q3 net income of 69.57 bill EQUITY | Nov 16, 2026, 12:08 PM UTC L HSBC raises Exelon price target to $48 from $44 EQUITY | Nov 16, 2026, 12:08 PM UTC M Tyson Foods shares fall 2% premarket after revenue forecast Tyson Foods shares are down 2% premarket after the company forecast a steeper-than-expected fall in revenue. EARNINGS | Nov 16, 2026, 12:08 PM UTC L Domino’s Launches Sweet Heat Smokehouse Pizza Nationwide Domino’s rolled out its new Sweet Heat Smokehouse Specialty Pizza at stores nationwide starting today. EQUITY | Nov 16, 2026, 12:08 PM UTC L TempraMed Signs Exclusive Qatar Distribution Deal With DayMed TempraMed signed an exclusive distribution deal with DayMed for Qatar. EQUITY | Nov 16, 2026, 12:08 PM UTC L RPT-GT BIOPHARMA Q3 INCOME FROM OPERATIONS USD -3.5 MILLION RPT-GT BIOPHARMA Q3 INCOME FROM OPERATIONS USD -3.5 MILLION FX | Nov 16, 2026, 12:08 PM UTC L Phillip Securities Upgrades Airbnb to Neutral From Reduce, Sets $184 Target EQUITY | Nov 16, 2026, 12:08 PM UTC L Goldman Sachs Trust Files Form N-CEN Goldman Sachs Trust filed Form N-CEN for Aug. 31. EQUITY | Nov 16, 2026, 12:08 PM UTC L HSBC Raises FirstEnergy Price Target to $51.50 From $50 HSBC adjusted its price target on FirstEnergy to $51.50 from $50. EQUITY | Nov 16, 2026, 12:08 PM UTC L Morgan Stanley Cuts Kennametal Price Target to $20 From $27 Morgan Stanley maintained its Underweight rating on Kennametal while lowering its price target from $27 to $20. EQUITY | Nov 16, 2026, 12:08 PM UTC L RPT-GT BIOPHARMA Q3 NET INCOME USD -3.5 MILLION RPT-GT BIOPHARMA Q3 NET INCOME USD -3.5 MILLION FX | Nov 16, 2026, 12:08 PM UTC M Blackstone Digital Infrastructure Trust Reports Third-Quarter 2026 Results Blackstone Digital Infrastructure Trust reported third-quarter 2026 net income of $15.6 million, or $0.15 per share. FFO per share was $0.15 and adjusted FFO per share was $0.17. EQUITY | Nov 16, 2026, 12:08 PM UTC L Nike to Become UEFA's Official Match Ball Provider Nike has agreed to become the Union of European Football Associations' official match ball provider. EQUITY | Nov 16, 2026, 12:08 PM UTC L Baidu Third-Quarter Results Fall Year Over Year Baidu's third-quarter results fell year over year amid online marketing weakness. EARNINGS | Nov 16, 2026, 12:08 PM UTC L Domino’s launches Sweet Heat Smokehouse pizza nationwide The pizza is available through the Mix & Match deal for $9.99 each for medium Specialty Pizzas when customers order two or more items. EQUITY | Nov 16, 2026, 12:08 PM UTC L Morgan Stanley Cuts Cummins Price Target to $588 From $761, Keeps Overweight Morgan Stanley lowered its price target on Cummins to $588 from $761 and maintained an Overweight rating. EQUITY | Nov 16, 2026, 12:08 PM UTC L Morgan Stanley Cuts Target Hospitality Price Target to $21, Keeps Overweight EQUITY | Nov 16, 2026, 12:08 PM UTC L HSBC Raises Duke Energy Price Target to $133.50 From $123 HSBC adjusted its price target on Duke Energy to $133.50 from $123. The report also says the stock has an average rating of overweight. EQUITY | Nov 16, 2026, 12:08 PM UTC H *--Earnings Flash (POET) POET Technologies Posts Q3 Revenue $1M, vs. FactSet Est of $1.6M *--Earnings Flash (POET) POET Technologies Posts Q3 Revenue $1M, vs. FactSet Est of $1.6M EARNINGS | Nov 16, 2026, 12:08 PM UTC L Reuters summarizes US analyst research on Nvidia, Phillips 66 and TransDigm A Reuters roundup covers analyst research on Nvidia, Phillips 66 and TransDigm Group. The supplied text does not include the specific actions. EQUITY | Nov 16, 2026, 12:08 PM UTC L GT Biopharma Swings to Q3 Net Loss of $3.5 Million GT Biopharma Swings to Q3 Net Loss of $3.5 Million GT Biopharma swung to a third-quarter 2026 ne EQUITY | Nov 16, 2026, 12:08 PM UTC H *--Earnings Flash (POET) POET Technologies Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.07 Loss *--Earnings Flash (POET) POET Technologies Posts Q3 Loss $0.04 a Share, vs. FactSet Est of $0.07 Loss EARNINGS | Nov 16, 2026, 12:08 PM UTC L Rubicon Organics Q3 2026 gross profit falls 36% year over year to CAD 5.14 million Rubicon Organics Q3 2026 gross profit falls 36% year over year to CAD 5.14 million Rubicon Organ EARNINGS | Nov 16, 2026, 12:07 PM UTC L Domino’s Launches Sweet Heat Smokehouse Pizza Domino’s Pizza Inc. launched its Sweet Heat Smokehouse Pizza, a new Specialty Pizza. EQUITY | Nov 16, 2026, 12:07 PM UTC